Hong et al, J Immunological Methods 120: 151-7.* |
Hellman et al, Handbook of Experimental Pharmacology 133(vaccines): 499-526, 1999.* |
Coupey et al, Cytokine 5(6): 564-9, Nov. 1993.* |
Zinkernagel et al, Immunol Rev 156: 199-209, Apr. 1997.* |
Banks et al, Chemistry and Pharmcology of Honey-bee venom In: Piek T, ed. Venoms of the Hyemoptera. London: Academic Press; 1986, pp. 329-416.* |
Guidry et al, J Dairy Science 77(10): 2965-74, 1994.* |
Hellman L. et al., Allergy Vaccines. A Review of Developments: Clinical Immunotherapeutics, ADIS International, Aug. 1996, pp. 130-142, vol. 6, No. 2, Auckland, NZ. |
Lambert, Laura A. et al: “Intranodal Immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor immunity.”, Cancer Research, Jan. 15, 2001, pp. 641-646, vol. 61, No. 2. |
L. Parijs, et al., “Homeostasis and Self-Tolerance in the Immune System: Turning Lymphocytes off”, Science, vol. 280, Apr. 10, 1998, pp. 243-248. |
R. Tepper, et al., “IL-4 Induces Allergic-like Inflammatory Disease and Alters T Cell Development in Transgenic Mice”, Cell, vol. 62, Aug. 10, 1990, pp. 457-467. |
P. Mark, et al., “Human T and B cell immune responses to Fel d 1 in cat-allergic and non-cat-allergic subjects”, Clinical and Experimental Allergy, vol. 26, 1996, pp. 1316-1328. |
A. Helbling, et al., “Allergy to honey: relation to pollen and honey bee allergy”, Allergy, vol. 47, Feb. 1992, pp. 41-49. |
M. dos Reis, et al., “Acute Renal Failure in Experimental Envenomation with Africanized Bee Venom”, Renal Failure, vol. 20, 1998, pp. 39-51. |
A Dirksen, et al., “Common Components in Pollen Extracts”, Allergy, vol. 35, 1980, pp. 611-616. |
H. de Groot, et al., “Allergy to bumblebee venom I. Occupational anaphylaxis to bumblebee venom: diagnosis and treatment”, Allergy, vol. 50, 1995, pp. 581-584. |
T. Lehner, et al., “Induction of Mucosal and Systemic Immunity to a Recombinant Simian Immunodeficiency Viral Protein”, Science, vol. 258, Nov. 20, 1992, pp. 1365-1369. |
T. Lehner., et al., “Mucosal Model of Genital Immunization in Male Rhesus Macaques with a Recombinant Simian Immunodeficiency Virus p27 Antigen”, Journal of Virology, vol. 68, Mar. 1994, pp. 1624-1632. |
T. Lehner, et al., “Targeted Lymph Node Immunization with Simian Immunodeficiency Virus p27 Antigen to Elicit Genital, Rectal, and Urinary Immune Responses in Nonhuman Primates”, Journal of Immunology, Aug. 15, 1994, vol. 153(4)pp. 1858-1868. |
B. Wallner, et al., “Peptide Therapy for Treatment of Allergic Disease”, Clinical Immunology and Immunopathology, vol. 80, No. 2, Aug. 1996, pp. 105-109. |
R. Valenta, et al., “The immunoglobulin E-allergen interaction: a target for therapy of type I allergic diseases”, Int. Arch Allergy Immunology 1998, 116: pp. 167-176. |
H. Malling, “Allergen-specific immunotherapy. Present state and directions for the future”, Allergy 1999, 54, pp. 30-33. |
C. Akdis, et al., “Immunologic mechanisms of specific immunotherapy”, Allergy 1999, 54, 31-32. |
E. Raz, et al., “Deviation of the Allergic IgE to an IgG Response by Gene Immunotherapy”, Intern. Rev. Immunol., vol. 18, pp. 271-289, 1999. |
D. Lee, et al., “Inhibition of IgE Antibody Formation by Plasmid DBA Immunization is Mediated by both CD4+ and CD8+ TCells”, Int. Arch Alergy Immunol 1997; 113: 227-230. |
J. McGhee, et al., “Mucosal Th1-versus Th2-Type Responses for Antibody-or Cell-Mediated Immunity to Simian Immunodeficiency Virus in Rhesus Macaques”, Journal of Infectious Diseases 1999; 179: pp. S480-S484. |
T. Lehner, et al., “Up-regulation of beta-chemokines and down-modulation of CCR5 receptors inhibit simian immunodeficiency virus transmission human primates” Immunology 2000; 99: pp. 569-577. |
S. Shinall, et al., “Identification of Murine Geminal Center B Cell Subsets Defined Expression of Surface Isotypes and Differentiation Antigens”, Journal of Immunology Jun. 1, 2000, vol. 164(11), pp. 5729-5738. |
H. Kitagaki, et al., “Distinct In Vivo and In Vitro Cytokine Profiles of Draining Lymph Node Cells in Acute and Chronic Phases of Contact Hypersensitivity: Importance of a Type 2 Cytokine-Rich Cutaneous Milieu for the Developemnt of an Early-Type Response in the Chronic Phases”, Journal of Immunology, 1999, 163: 1265-1273. |
A. Aubertin, et al., “Generation of CD8+ T Cell-Generation Suppressor Factor and β-Chemokines by Targeted Iliac Lymph Node Immunization in Rhesus Monkeys Challenged with SHIV-89.6P by the Rectal Route”, Aids Research and Human Retroviruses 2000, vol. 16, pp. 381-392. |